11 Best Guru Stocks to Buy According to Wall Street Analysts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
Moonlake Immunotherapeutics (MLTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 171,600 | $6,704,412 | 1.88% | |
| 2. | BIT Capital GmbH Jan Beckers | 14,610 | $570,813 | -30% | 0.05% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 10,000 | $390,700 | +60% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.90 | 58,839 | 8,494,151 | 2023-10-05 | Filing | ||
| $57.32 | 67,814 | 8,435,312 | 2023-10-04 | Filing | ||
| $57.25 | 150,487 | 8,367,498 | 2023-10-03 | Filing | ||
| $57.37 | 74,911 | 8,217,011 | 2023-10-02 | Filing | ||
| $50.00 | 800,000 | 4,927,100 | 2023-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.00 | 132,549 | Large Shareholder, Director | 1,287,768 | 2024-10-04 | Filing | |
| $50.00 | 836,862 | Large Shareholder, Director | 8,168,838 | 2024-10-04 | Filing | |
| $50.00 | 1,030,589 | Large Shareholder, Director | 10,235,089 | 2024-10-04 | Filing | |
| $53.72 | 171,000 | Director | 171,980 | 2024-10-04 | Filing | |
| $55.89 | 4,740 | Officer, Director | 2,982,814 | 2024-02-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,434,770 | $56,056,464 | 0.27% | |
| 2. | 1,292,608 | $50,502,195 | 0.01% | |
| 3. | 1,269,351 | $49,593,543 | 0.11% | |
| 4. | 322,114 | $12,584,994 | 0.01% | |
| 5. | 286,209 | $11,182,185 | 0% |
News See All
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022.
10 Best Guru Stocks To Buy Now
Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, picking the right set of vehicles to either preserve or grow money can often seem to be a ...
10 Worst ADR Stocks To Buy According to Short Sellers
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank that represents shares of a foreign company. These certificates allow U.S.
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
5 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the five best performing NASDAQ stocks in 2023.
5 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the five best performing biotechnology stocks in 2023.
5 Best-Performing Stocks in the Last 12 Months
Property and casualty insurance company United Insurance Holdings Corp. (NASDAQ:UIHC) has been one of the best-performing stocks over the past one year.